Direct effects of thyroid hormones on hepatic lipid metabolism

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Nature Reviews Endocrinology

• Publication date

  2018-02-23

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nrendo.2018.10PMID 29472712PMCID PMC6013028
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Subclinical Hypothyroidism and Low‐Normal Thyroid Function Are Associated With Nonalcoholic Steatohepatitis and Fibrosis

  2018cited by this paper
• Thyroid Hormone Signaling Pathways: Time for a More Precise Nomenclature.

  2017cited by this paper
• Hypothalamic AMPK-ER Stress-JNK1 Axis Mediates the Central Actions of Thyroid Hormones on Energy Balance

  2017cited by this paper
• Metabolomic analysis shows differential hepatic effects of T2 and T3 in rats after short-term feeding with high fat diet

  2017cited by this paper
• Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases

  2017cited by this paper
• Thyroid Hormone Stimulation of Autophagy Is Essential for Mitochondrial Biogenesis and Activity in Skeletal Muscle.

  2016cited by this paper
• Molecular Pathogenesis of NASH

  2016cited by this paper
• Thyroid hormone-mediated autophagy and mitochondrial turnover in NAFLD

  2016cited by this paper
• Thyroid Hormone Mimetics: the Past, Current Status and Future Challenges

  2016cited by this paper
• Non-alcoholic fatty liver disease.

  2016cited by this paper
• Regulation and Functions of Autophagic Lipolysis.

  2016cited by this paper
• NAFLD and liver transplantation: Current burden and expected challenges.

  2016cited by this paper
• Physiological and Metabolic Changes During the Transition from Hyperthyroidism to Euthyroidism in Graves' Disease

  2016cited by this paper
• Nongenomic actions of thyroid hormone

  2016cited by this paper
• Atherogenic Lipoproteins in Subclinical Hypothyroidism and Their Relationship with Hepatic Lipase Activity: Response to Replacement Treatment with Levothyroxine

  2016cited by this paper
• 3,5-diiodo-L-thyronine: A Possible Pharmacological Agent?

  2016cited by this paper
• Thyroid Function and the Risk of Nonalcoholic Fatty Liver Disease: The Rotterdam Study.

  2016cited by this paper
• FT3/FT4 ratio predicts non-alcoholic fatty liver disease independent of metabolic parameters in patients with euthyroidism and hypothyroidism

  2016cited by this paper
• Sobetirome: the past, present and questions about the future

  2016cited by this paper
• Chemical Hybridization of Glucagon and Thyroid Hormone Optimizes Therapeutic Impact for Metabolic Disease.

  2016cited by this paper
• Triglyceride Mobilization from Lipid Droplets Sustains the Anti-Steatotic Action of Iodothyronines in Cultured Rat Hepatocytes

  2016cited by this paper
• Transcriptional regulation of hepatic lipogenesis

  2015cited by this paper
• Thyroid hormone induction of mitochondrial activity is coupled to mitophagy via ROS-AMPK-ULK1 signaling

  2015cited by this paper
• Hepatic FOXO1 Target Genes Are Co-regulated by Thyroid Hormone via RICTOR Protein Deacetylation and MTORC2-AKT Protein Inhibition*

  2015cited by this paper
• Thyroid-stimulating hormone decreases HMG-CoA reductase phosphorylation via AMP-activated protein kinase in the liver

  2015cited by this paper
• Thyroid function is associated with non-alcoholic fatty liver disease in euthyroid subjects

  2015cited by this paper
• Local hypothyroidism favors the progression of preneoplastic lesions to hepatocellular carcinoma in rats

  2015cited by this paper
• Perinatal deiodinase 2 expression in hepatocytes defines epigenetic susceptibility to liver steatosis and obesity

  2015cited by this paper
• Non-alcoholic fatty liver disease in 2015.

  2015cited by this paper
• Subclinical and clinical hypothyroidism and non-alcoholic fatty liver disease: a cross-sectional study of a random population sample aged 18 to 65 years

  2015cited by this paper
• Thyroid-stimulating hormone regulates hepatic bile acid homeostasis via SREBP-2/HNF-4α/CYP7A1 axis.

  2015cited by this paper
• Cellular Action of Thyroid Hormone

  2014cited by this paper
• Thyroid Hormone Levels in Obese Children and Adolescents with Non-Alcoholic Fatty Liver Disease

  2014cited by this paper
• Regulation of fatty acid composition and lipid storage by thyroid hormone in mouse liver

  2014cited by this paper
• Lysosomal acid lipase deficiency--an under-recognized cause of dyslipidaemia and liver dysfunction.

  2014cited by this paper
• Thyroid Hormone Upregulates Zinc-α2-glycoprotein Production in the Liver but Not in Adipose Tissue

  2014cited by this paper
• 3,5-Diiodo-L-Thyronine Modifies the Lipid Droplet Composition in a Model of Hepatosteatosis

  2014cited by this paper
• Thyroid hormone regulation of hepatic lipid and carbohydrate metabolism.

  2014cited by this paper
• Discovery of 2-[3,5-dichloro-4-(5-isopropyl-6-oxo-1,6-dihydropyridazin-3-yloxy)phenyl]-3,5-dioxo-2,3,4,5-tetrahydro[1,2,4]triazine-6-carbonitrile (MGL-3196), a Highly Selective Thyroid Hormone Receptor β agonist in clinical trials for the treatment of dyslipidemia.

  2014cited by this paper
• Non-alcoholic fatty liver disease and thyroid dysfunction: a systematic review.

  2014cited by this paper
• Thyroid hormone analogues and derivatives: Actions in fatty liver.

  2014cited by this paper
• Repair-Related Activation of Hedgehog Signaling in Stromal Cells Promotes Intrahepatic Hypothyroidism

  2014cited by this paper
• Effect of Fructose and 3,5-Diiodothyronine (3,5-T2) on Lipid Accumulation and Insulin Signalling in Non-Alcoholic Fatty Liver Disease (NAFLD)-Like Rat Primary Hepatocytes

  2014cited by this paper
• Thyroid hormone regulation of metabolism.

  2014cited by this paper
• Hypothalamic effects of thyroid hormones on metabolism.

  2014cited by this paper
• Lysosome: regulator of lipid degradation pathways

  2014cited by this paper
• Thyrotropin increases hepatic triglyceride content through upregulation of SREBP-1c activity.

  2014cited by this paper
• Chromosome 19 open reading frame 80 is upregulated by thyroid hormone and modulates autophagy and lipid metabolism

  2014cited by this paper
• NCoR1 and SMRT Play Unique Roles in Thyroid Hormone Action In Vivo

  2014cited by this paper
• Lipid lowering effects of iodothyronines: In vivo and in vitro studies on rat liver.

  2014cited by this paper
• The thyroid receptor β modulator GC-1 reduces atherosclerosis in ApoE deficient mice.

  2014cited by this paper
• Thyroid hormone reduces PCSK9 and stimulates bile acid synthesis in humans[S]

  2014cited by this paper
• Thyroid hormone receptor-β agonists prevent hepatic steatosis in fat-fed rats but impair insulin sensitivity via discrete pathways.

  2013cited by this paper
• Decreased Expression of Hepatic Low-Density Lipoprotein Receptor–Related Protein 1 in Hypothyroidism: A Novel Mechanism of Atherogenic Dyslipidemia in Hypothyroidism

  2013cited by this paper
• Insulin signalling mechanisms for triacylglycerol storage

  2013cited by this paper
• Hepatic fatty acid trafficking: multiple forks in the road.

  2013cited by this paper
• Human stearoyl-CoA desaturase 1 (SCD-1) gene expression is negatively regulated by thyroid hormone without direct binding of thyroid hormone receptor to the gene promoter.

  2013cited by this paper
• FoxO1 Deacetylation Regulates Thyroid Hormone-induced Transcription of Key Hepatic Gluconeogenic Genes*

  2013cited by this paper
• Non-classic thyroid hormone signalling involved in hepatic lipid metabolism.

  2013cited by this paper
• Thyroid hormone negatively regulates CDX2 and SOAT2 mRNA expression via induction of miRNA-181d in hepatic cells.

  2013cited by this paper
• 3,5-Diiodo-L-Thyronine Administration To Hypothyroid Rats Rapidly Enhances Fatty Acid Oxidation Rate and Bioenergetic Parameters in Liver Cells

  2013cited by this paper
• Prevalence of Hypothyroidism in Nonalcoholic Fatty Liver Disease

  2012cited by this paper
• 3,5,3′triiodo‐L‐thyronine induces SREBP‐1 expression by non‐genomic actions in human HEP G2 cells

  2012cited by this paper
• Influence of Neonatal Hypothyroidism on Hepatic Gene Expression and Lipid Metabolism in Adulthood

  2012cited by this paper
• Thyroid hormone reduces cholesterol via a non-LDL receptor-mediated pathway.

  2012cited by this paper
• Thyroid hormone stimulates hepatic lipid catabolism via activation of autophagy.

  2012cited by this paper
• Role of Sirtuin 1 in the Regulation of Hepatic Gene Expression by Thyroid Hormone*

  2012cited by this paper
• Thyroid hormone receptor-α gene knockout mice are protected from diet-induced hepatic insulin resistance.

  2012cited by this paper
• Liver triacylglycerol lipases.

  2012cited by this paper
• Non-alcoholic fatty liver disease across the spectrum of hypothyroidism.

  2012cited by this paper
• Stimulation of murine biliary cholesterol secretion by thyroid hormone is dependent on a functional ABCG5/G8 complex

  2012cited by this paper
• Identification and functions of the plasma membrane receptor for thyroid hormone analogues.

  2011cited by this paper
• Sobetirome: a selective thyromimetic for the treatment of dyslipidemia.

  2011cited by this paper
• Hepatic organic anion transporting polypeptide transporter and thyroid hormone receptor interplay determines cholesterol and glucose homeostasis

  2011cited by this paper
• Nonthyrotoxic Prevention of Diet-Induced Insulin Resistance by 3,5-Diiodo-L-Thyronine in Rats

  2011cited by this paper
• Association between thyroid function and nonalcoholic fatty liver disease in euthyroid elderly Chinese

  2011cited by this paper
• Direct effects of iodothyronines on excess fat storage in rat hepatocytes.

  2011cited by this paper
• Non-receptor-mediated actions are responsible for the lipid-lowering effects of iodothyronines in FaO rat hepatoma cells.

  2011cited by this paper
• Coordination of mitochondrial biogenesis by thyroid hormone.

  2011cited by this paper
• Thyroid Hormone Regulates Hepatic Expression of Fibroblast Growth Factor 21 in a PPARα-dependent Manner*

  2010cited by this paper
• The Liver-Selective Thyromimetic T-0681 Influences Reverse Cholesterol Transport and Atherosclerosis Development in Mice

  2010cited by this paper
• Thyroid hormones, mitochondrial bioenergetics and lipid handling.

  2010cited by this paper
• Use of the thyroid hormone analogue eprotirome in statin-treated dyslipidemia.

  2010cited by this paper
• Thyroid hormone mimetics: potential applications in atherosclerosis, obesity and type 2 diabetes

  2009cited by this paper
• Hepatic Autophagy Is Suppressed in the Presence of Insulin Resistance and Hyperinsulinemia

  2009cited by this paper
• DITPA (3,5-Diiodothyropropionic Acid), a Thyroid Hormone Analog to Treat Heart Failure: Phase II Trial Veterans Affairs Cooperative Study

  2009cited by this paper
• Carbohydrate response element binding protein gene expression is positively regulated by thyroid hormone.

  2009cited by this paper
• Thyroid hormone effects on whole-body energy homeostasis and tissue-specific fatty acid uptake in vivo.

  2009cited by this paper
• Reduction of hepatic steatosis in rats and mice after treatment with a liver‐targeted thyroid hormone receptor agonist

  2009cited by this paper
• Distinct dysregulation of lipid metabolism by unliganded thyroid hormone receptor isoforms.

  2009cited by this paper
• Thyroid hormone β receptor activation has additive cholesterol lowering activity in combination with atorvastatin in rabbits, dogs and monkeys

  2009cited by this paper
• Association between hypothyroidism and hepatocellular carcinoma: A case‐control study in the United States

  2009cited by this paper
• Autophagy regulates lipid metabolism

  2009cited by this paper
• Mantle skewness and ridge segmentation

  2009cited by this paper
• Thyroid hormone-related regulation of gene expression in human fatty liver.

  2009cited by this paper
• Hepatic regulation of fatty acid synthase by insulin and T3: evidence for T3 genomic and nongenomic actions.

  2008cited by this paper
• Thyroid hormone (T3) and TRβ agonist GC‐1 inhibit/reverse nonalcoholic fatty liver in rats

  2008cited by this paper
• Thyroid hormone activates adenosine 5'-monophosphate-activated protein kinase via intracellular calcium mobilization and activation of calcium/calmodulin-dependent protein kinase kinase-beta.

  2008cited by this paper
• Anti-obesity, anti-diabetic, and lipid lowering effects of the thyroid receptor beta subtype selective agonist KB-141.

  2008cited by this paper
• A mutant thyroid hormone receptor alpha antagonizes peroxisome proliferator-activated receptor alpha signaling in vivo and impairs fatty acid oxidation.

  2007cited by this paper

• The thyroid hormone receptor beta (THR-β) agonist resmetir for the treatment of liver fi brosis and steatohepatitis

  2026cites this paper
• Navigating thyroid hormone signaling in liver fibrosis: mechanisms and clinical implications.

  2026cites this paper
• Another pleiotropic effect of SGLT2 inhibitors: Is it a new frontier in thyroid function regulation?

  2026cites this paper
• THYROID HORMONES DRIVE CENTRAL NERVOUS SYSTEM REMODELLING DURING FLATFISH METAMORPHOSIS.

  2026cites this paper
• The antithyroid drug methimazole as an emerging aquatic contaminant: Physiological and reproductive disruption in female goldfish (Carassius auratus) and partial mitigation by thyroxine

  2026cites this paper
• Eyelid Xanthelasma and Cardiovascular Outcomes: A Propensity-Matched Analysis.

  2026cites this paper
• NAFLD and Hypothyroidism: Deciphering Pivotal Genetic Variants, Cellular Expression Landscapes, and Spatial Architectures.

  2026cites this paper
• Different fatty acid patterns in serum in patients with various thyroid diseases

  2026cites this paper
• Targeting THR-β for MASLD Treatment: Current Progression and Emerging Prospects.

  2026cites this paper
• Evaluation of thyroid function in patients diagnosed with metabolic dysfunction-associated fatty liver disease: a cross-sectional study

  2026cites this paper
• The role of Race and Ethnicity in the response to MASLD treatment: A Review.

  2026cites this paper
• Farnesyl Diphosphate Synthase Promotes Proliferation of Hepatocellular Carcinoma Cells by Interacting With Glucose‐6‐Phosphate Dehydrogenase

  2026cites this paper
• The impact of hypothyroidism on the risk of intrahepatic cholestasis of pregnancy: a large-scale study based on pregnant women with hypothyroidism in Shanghai, China

  2026cites this paper
• Iodoquinoline-Biofortified Lettuce as a Safe and Bioavailable Dietary Iodine Source: In Vivo Study in Rats

  2025cites this paper
• Exploring socio-economic, biochemical, and genetic factors influencing thyroid status in Indian school-going adolescents.

  2025cites this paper
• Quick glance at 'metabolic dysfunction associated steatotic liver disease' therapeutics: Targets, trials, and trends

  2025cites this paper
• Estimation of Resistin and Adiponectin Levels in Iraqi Women with Hypothyroidism

  2025cites this paper
• The association between gestational hypothyroidism in pregnant women with preeclampsia, maternal liver function indicators, and neonatal birth weight: a study in Chinese pregnant women

  2025cites this paper
• Associations of urinary iodine concentration (UIC) with Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) among non-diabetic population: analysis of the NHANES 2017–2020

  2025cites this paper
• Dietary Supplementation with Chenodeoxycholic Acid or Ursodeoxycholic Acid Modulates Growth, Thyroid Status, and Hepatopancreatic–Intestinal Health in Juvenile Little Yellow Croaker Larimichthys polyactis

  2025cites this paper
• Nuclear receptors in metabolic, inflammatory, and oncologic diseases: mechanisms, therapeutic advances, and future directions

  2025cites this paper
• TSH as a novel biomarker for recurrence of hypertriglyceridemia pancreatitis: a clinical predictive tool linking lipid dysregulation to inflammation.

  2025cites this paper
• A multipart phase 1 study of the safety, pharmacodynamics and pharmacokinetics of ALG‐055009, a novel thyroid hormone receptor beta (THR‐β) agonist for metabolic dysfunction‐associated steatohepatitis (MASH), in healthy participants

  2025cites this paper
• ECM remodeling in hypothyroidism-associated MAFLD: mechanisms, clinical relevance, and therapeutic targets

  2025cites this paper
• Raman Spectroscopic Characterization of Liver Steatosis and Fibrosis in a 2D and 3D in vitro Thyroxine-Treated Hypothyroid Cellular Model.

  2025cites this paper
• Resmetirom, the first FDA-approved drug for MASH: From drug discovery and action mechanisms to clinical trials

  2025cites this paper
• Hypothyroidism, atherosclerosis and cardiovascular risk prevention.

  2025cites this paper
• Association Between Thyroid Dysfunction and Non-Alcoholic Fatty Liver Disease: A Systematic Review

  2025cites this paper
• Genetic susceptibility to gestational diabetes and its mild modification by bisphenol A and thyroid-stimulating hormone: findings from a South Chinese pregnancy cohort

  2025cites this paper
• Oral Supplementation of Indole-3-acetic Acid Alleviates High-Fat-Induced Obesity by Activating the Gpha2-Mediated Thyroid-Stimulating Hormone Pathway.

  2025cites this paper
• Impact of Graves’ hyperthyroidism treatment on lipid profiles and cholesterol dynamics: a prospective observational study

  2025influential citation
• Lifestyle Interventions to Tackle Cardiovascular Risk in Thyroid Hormone Signaling Disorders

  2025cites this paper
• Non-rhythmic modulators of the circadian system: A new class of circadian modulators.

  2025cites this paper
• Association between the newly proposed dietary index for gut microbiota and thyroid function: NHANES 2007–2012

  2025cites this paper
• Dyslipidemia Unmasked by the Treatment of Graves’ Disease: The Link Between Cholesterol Metabolism and Thyroid Hormones

  2025influential citation
• Association of coexposure to per- and polyfluoroalkyl substances and heavy metals with thyroid function across varied age pregnant women and the potential role of hemoglobin.

  2025cites this paper
• Thyroid Hormone Sensitivity as a Possible Determinant of Metabolic Phenotypes in Young Adults, Not in the Elderly.

  2025cites this paper
• Hidden in the Fat: Unpacking the Metabolic Tango Between Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Syndrome

  2025cites this paper
• Endurance Training Alleviates Metabolic‐Associated Fatty‐Liver Disease (MAFLD)‐Related Testicular Impairments via Endoplasmic Reticulum Stress Regulation

  2025cites this paper
• Thyroid-Stimulating Hormone: An Important Target for the Prevention of Nonalcoholic Fatty Liver Disease

  2025cites this paper
• Fin Whale as a Sink of Legacy and Emerging Contaminants: First Integrated Chemical Exposomics and Gene Expression Analysis in Cetaceans

  2025cites this paper
• Reactive Oxygen Species as Key Molecules in the Pathogenesis of Alcoholic Fatty Liver Disease and Nonalcoholic Fatty Liver Disease: Future Perspectives

  2025cites this paper
• Injinoryeong-San Attenuates Metabolic Dysfunction-associated Steatohepatitis via Regulation of YAP/TAZ-Signaling Pathway.

  2025cites this paper
• Effect of resmetirom on lipid profile and adiponectin levels.

  2025cites this paper
• Co-exposure to bisphenol a and arsenic enhance hepatotoxicity in zebrafish by targeting the hypothalamic-pituitary-thyroid axis and PPAR pathway.

  2025cites this paper
• A scoping review on the possible immunometabolic properties of the furan fatty acid metabolite 3-carboxy-4-methyl-5-propyl-2-furanpropionic acid.

  2025cites this paper
• Impaired Thyroid Hormone Sensitivity is Associated with Increased Risk of Liver Fibrosis in Euthyroid Population: A Cross-Sectional Analysis of NHANES

  2025cites this paper
• Resmetirom: The First FDA-Approved Drug for Metabolic Dysfunction-Associated Steatohepatitis (MASH) with a Perspective on Precision Medicine

  2025influential citation
• Effect of impaired sensitivity to thyroid hormones on the risk of insulin resistance and dyslipidemia in polycystic ovary syndrome patients

  2025cites this paper
• Pubertal exposure to glyphosate-based herbicide aggravates diet-induced steatosis and hormonal dysregulation in adult mice

  2025cites this paper
• Discovery of the Insecticide Chlorantraniliprole as a Thyroid Hormone Receptor β Antagonist Reinforcing Thyroid-Liver Metabolic Disruption to Promote Metabolic Dysfunction-Associated Steatotic Liver Disease.

  2025cites this paper
• Endocrine Disorders and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Narrative Review

  2025cites this paper
• Extrahepatic effects of thyroid hormone and resmetirom override their beneficial hepatic effects in alcohol-associated liver disease in mice

  2025cites this paper
• COMBINED DISORDER: CURRENT STATUS OF METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE IN PATIENTS WITH HYPOTHYROIDISM AND PROSPECTS FOR PATIENT PATHWAY IMPLEMENTATION

  2025cites this paper
• Resmetirom: The First Disease-Specific Treatment for MASH

  2025cites this paper
• The role of hypothyroidism in cirrhosis pathogenesis: A retrospective cohort study and multi-omics integration analysis

  2025cites this paper
• Differences between therapeutic mechanisms of resmetirom and semaglutide against MASH in western diet-fed MC4R-knockout mice

  2025cites this paper
• 2025 Medicinal Chemistry Reviews

  2025cites this paper
• Low-normal free thyroxine is associated with a higher prevalence of lower extremity arterial disease in euthyroid type 2 diabetes mellitus

  2025cites this paper
• The predictive value of the FT3/FT4 ratio for the severity of coronary artery disease in patients with acute coronary syndrome

  2025cites this paper
• Evaluation of Adropin, Irisin and Cytokeratin 18 as Biomarkers in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Comparative Clinical Study

  2025cites this paper
• Exploring the Ayurvedic Diagnosis through Nidana Panchaka’s and the Role of Dhatvagnimandyata in the Pathophysiology of Hypothyroidism - A Comprehensive Review

  2025cites this paper
• Integrated computational analysis of molecular mechanisms underlying perfluorooctane sulfonic acid induced thyroid toxicity

  2025cites this paper
• Association of the thyroid hormone sensitivity index with triglycerides in adolescents: a cross-sectional study

  2025cites this paper
• Update in non-alcoholic fatty liver disease management: role of sodium-glucose cotransporter 2 inhibitors.

  2025cites this paper
• Metabolic dysfunction-associated steatotic liver disease (MASLD): a systemic disease with a variable natural history and challenging management

  2025cites this paper
• Inhibition of macrophage inflammasome assembly and pyroptosis with GC-1 ameliorates acute lung injury

  2025cites this paper
• Μetabolic dysfunction-associated steatotic liver disease: a condition of heterogeneous metabolic risk factors, mechanisms and comorbidities requiring holistic treatment

  2025cites this paper
• At the Crossroads of Health and Disease: Consequences of Fat in the Liver

  2025cites this paper
• The protective effects and mechanism of myricetin in liver diseases (Review)

  2025cites this paper
• Hypothyroidism/subclinical hypothyroidism and metabolic dysfunction-associated steatotic liver disease: advances in mechanism and treatment

  2025cites this paper
• Two or three weeks of thyroid hormone withdrawal before initial 131I therapy for patients with differentiated thyroid carcinoma?

  2025cites this paper
• Endocrine regulation of circadian rhythms

  2025cites this paper
• Role of serum fasting glucagon in hypothyroidism-related nonalcoholic fatty liver disease

  2025cites this paper
• Differential lipids in euthyroid pregnant women with positive TPOAb and its correlation with clinical parameters

  2025cites this paper
• Thyroid Stimulating Hormone Levels Are Related to Fatty Liver Indices Independently of Free Thyroxine: A Cross-Sectional Study

  2025cites this paper
• Evaluation of the hepatic and subcutaneous adipose tissue effects of triiodothyronine treatment in an animal model of metabolic syndrome.

  2025cites this paper
• Inflammation in MASLD progression and cancer

  2025cites this paper
• Free triiodothyronine and triglyceride-glucose index interaction on metabolic dysfunction-associated steatotic liver disease risk in euthyroid individuals

  2025cites this paper
• A novel ASGR1-Targeting nanocomplex for mitigating donor liver steatosis

  2025cites this paper
• Exposure to polycyclic aromatic hydrocarbons, heavy metals, and per- and polyfluoroalkyl substances and their associations with serum lipid profiles in the general Korean adult population

  2025cites this paper
• Key Scientific Achievements in Gastroenterology in 2024: Meeting of the Internal Medicine Sciences’ Council of the Department of Medical Sciences of the Russian Academy of Sciences

  2025cites this paper
• Lipoprotein(a)—Investigating Sex-Based Differences Across the Lifespan in Men and Women

  2025cites this paper
• Metabolic and Functional Cross Talk Between the Thyroid and Liver

  2025cites this paper
• Serum metabolomics reveals systemic metabolic alterations of Graves’ disease before and after antithyroid drug treatment

  2025cites this paper
• Alnustone Ameliorates Metabolic Dysfunction‐Associated Steatotic Liver Disease by Facilitating Mitochondrial Fatty Acid β‐Oxidation via Targeting Calmodulin

  2025cites this paper
• MIF-mediated crosstalk between THRSP+ hepatocytes and CD74+ lipid-associated macrophages in hepatic periportal zone drives MASH.

  2025cites this paper
• Effects of exogenous phytase supplementation on the modulation of hormonal responses in Japanese quails (Coturnix japonica) at high environmental temperatures during the production phase

  2025cites this paper
• Lipid Hormones at the Intersection of Metabolic Imbalances and Endocrine Disorders

  2025cites this paper
• Regulation of RPE65 expression in human retinal pigment epithelium cells

  2025cites this paper
• Insulinotropic and Beta-Cell Proliferative Effects of Unripe Artocarpus heterophyllus Extract Ameliorate Glucose Dysregulation in High-Fat-Fed Diet-Induced Obese Mice

  2025cites this paper
• Resmetirom in the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease and Steatohepatitis

  2025cites this paper
• The thyroid hormone receptor beta (TR-β) signaling controls pathogenic Th17 cells in autoimmune disease.

  2025cites this paper
• Exploring causal links between autoimmune liver diseases, chronic hepatitis C, and thyroid disorders: Evidence from NHANES and GWAS studies

  2025cites this paper
• Co-exposure to enrofloxacin and atrazine enhances the hepatotoxicity in Larimichthys crocea by targeting the hypothalamic-pituitary-thyroid and gut-liver axes.

  2025cites this paper
• KYLO-0603, a novel liver-targeting, thyroid hormone receptor-β agonist for the inhibition of MASH progression

  2025cites this paper
• Impaired thyroid hormone sensitivity is associated with the degrees of fatty infiltration in metabolic dysfunction associated steatotic liver disease

  2025cites this paper
• Association Between Thyroid Hormone Sensitivity and Non-Alcoholic Fatty Liver Disease in Individuals with Normal Thyroid Function

  2025cites this paper
• Thyroid Hormone Resistance Indices and Their Correlations With Insulin Resistance in Chinese Euthyroid Subjects

  2025cites this paper
• Association of Sensitivity to Thyroid Hormones and Non-Alcoholic Fatty Liver Disease and the Severity of Liver Fibrosis in Euthyroid Adults: A Retrospective Study

  2025cites this paper